Stolberg M. The miraculous effects of taking laxatives. Success and failure of pre-modern medical treatment from the patients' perspective. Wurzbg Medizinhist Mitt. 2003;22:167-77.

Picard D, Kao CC, Hudak KA, et al. Pokeweed antiviral protein inhibits brome mosaic virus replication in plant cells. J Biol Chem. 2005;280:20069-75.

Uckun FM, Rustamova L, Vassilev AO, et al. CNS activity of pokeweed anti-viral protein (PAP) in mice infected with lymphocytic choriomeningitis virus (LCMV). BMC Infect Dis. 2005;5:9.

Parikh BA, Baykal U, Di R, et al. Evidence for retro-translocation of pokeweed antiviral protein from endoplasmic reticulum into cytosol and separation of its activity on ribosomes from its activity on capped RNA. Biochemistry. 2005;44:2478-90.

D'Cruz OJ, Waurzyniak B, Uckun FM, et al. Mucosal toxicity studies of a gel formulation of native pokeweed antiviral protein. Toxicol Pathol. 2004;32:212-21.

D'Cruz OJ, Waurzyniakt B, Uckun FM, et al. A 13-week subchronic intravaginal toxicity study of pokeweed antiviral protein in mice. Phytomedicine. 2004;11:342-51.

Parikh BA, Tumer NE. Antiviral activity of ribosome inactivating proteins in medicine. Mini Rev Med Chem. 2004;4:523-43.

Hudak KA, Bauman JD, Tumer NE, et al. Pokeweed antiviral protein binds to the cap structure of eukaryotic mRNA and depurinates the mRNA downstream of the cap. RNA. 2002;8:1148-59.

Parikh BA, Coetzer C, Tumer NE, et al. Pokeweed antiviral protein regulates the stability of its own mRNA by a mechanism that requires depurination but can be separated from depurination of the alpha-sarcin/ricin loop of rRNA. J Biol Chem. 2002;277:41428-37.

Turpin JA. Considerations and development of topical microbicides to inhibit the sexual transmission of HIV. Expert Opin Investig Drugs. 2002;11:1077-97.

Yamaguchi K, Uechi M, Katakura Y, et al. Mitogenic properties of pokeweed lectin-D isoforms on human peripheral blood lymphocytes: non-mitogen PL-D1 and mitogen PL-D2. Biosci Biotechnol Biochem. 2004;68:1591-3.

Yan S, Marguet D, Dobers J, et al. Deficiency of CD26 results in a change of cytokine and immunoglobulin secretion after stimulation by pokeweed mitogen. Eur J Immunol. 2003;33:1519-27.

Barabas E, Kemeny B, Gonzalez R, et al. A comparison of the lymphoproliferative capacity of pokeweed mitogen (PWM) and phytohaemagglutinin (PHA) in CCR-5 wild-type and heterozygous HIV-infected and uninfected subjects. Int J STD AIDS. 2002;13:691-7.

Wang S, Panter KE, Evans RC, et al. The effects of pokeweed mitogen (PWM) and phytohemagglutinin (PHA) on bovine oocyte maturation and embryo development in vitro. Anim Reprod Sci. 2001;67:215-20.

Wimer BM, Mann PL. Mitogen immunotherapy for HIV infections exemplified by phytohemagglutinin and pokeweed mitogen. Cancer Biother Radiopharm. 2001;15:629-44.

Wimer BM, Mann PL. Apparent pokeweed mitogen cure of metastatic gum melanoma in an older dog. Cancer Biother Radiopharm. 2000;15:201-5.

Sjoberg O, Kurnick J. Conditions for induction of specific and polyclonal antibody production by Cowan 1 bacteria and by pokeweed mitogen. Scand J Immunol. 1998;11:47-51.

Lazarus DD, Trimble LA, Moldawer LL, et al. The metabolic effects of pokeweed mitogen in mice. Metabolism. 1998;47:75-82.

Newall CA, Anderson LA, Phillipson JD. Herbal Medicines: A Guide for Health-Care Professionals. London: The Pharmaceutical Press. 1996:215-217.

Roberge R, Brader E, Martin ML, et al. The root of evil-pokeweed intoxication. Ann Emerg Med. 1986;15:470-3.

Barker BE et al. Haematological effects of pokeweed. Lancet 1967;1:437.

Barker BE et al. Peripheral blood plasmacytosis following systemic exposure to Phytolacca americana (pokeweed). Pediatrics. 1966;38:490-493.

Barker BE et al. Mitogenic activity in Phytolacca americana (pokeweed). Lancet. 1965;1:170.

Yamaguchi K, Uechi M, Katakura Y, et al. Mitogenic properties of pokeweed lectin-D isoforms on human peripheral blood lymphocytes: non-mitogen PL-D1 and mitogen PL-D2. Biosci Biotechnol Biochem. 2004;68:1591-3.